News

Researchers at the University of Cincinnati are exploring ways to interrupt the lifecycle of the parasite behind Chagas ...
First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced ...
COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV ...
Chagas disease is often called a silent killer because many people don't realize they have it until complications from the ...
We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...
University of Cincinnati biologists are studying the lifecycle of the Chagas disease parasite to develop a cure, aiming to ...
A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
Researchers examined which participants developed kidney disease severe enough to require a dialysis known as continuous renal replacement therapy.
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine ...
NEW HAVEN, Conn. (WTNH) — A potential breakthrough in treating Lyme disease with a possible vaccine is on the horizon. The disease and others are spread by tick bites. “The deer tick transmits ...
A scientist wants to know With that in mind, the London resident and Fanshawe College horticulture instructor signed up for a clinical study for a new, potential Lyme disease vaccine. The clinical ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to ...